How do I know if my Leukemia has an actionable mutation

Understanding Actionable Mutations in Leukemia

Great question—this is one of the most important things your care team will determine after diagnosis. Let me explain what this means and how doctors figure it out.

What Are Actionable Mutations?

An actionable mutation is a genetic change in your leukemia cells that doctors can specifically target with treatment. Think of it like this: if your leukemia has a particular "lock," there's a specific "key" (targeted therapy) that can open it.

According to the NCCN Guidelines for Patients: Acute Myeloid Leukemia, genetic and biomarker testing is used to:

• Learn more about your specific subtype of AML
• Target treatment (this is the actionable part)
• Determine the likely course your cancer will take

How Doctors Find Actionable Mutations

Your care team will perform several types of genetic tests on your leukemia cells:

Common testing methods include:

• Karyotype - A picture of your chromosomes to look for missing, extra, or rearranged pieces
• FISH (Fluorescence In Situ Hybridization) - Uses special dyes to find specific genetic changes that are too small to see under a regular microscope
• Next-Generation Sequencing (NGS) - Reads your DNA in detail to find mutations other methods might miss
• PCR (Polymerase Chain Reaction) - Can detect even 1 abnormal cell among 100,000 normal cells, which is important for monitoring treatment response

According to the NCCN Guidelines, some mutations may determine the type of treatment given.

Examples of Actionable Mutations

Different types of leukemia have different actionable mutations:

• In CML (Chronic Myeloid Leukemia): The BCR::ABL1 gene is the hallmark mutation. Per the NCCN Guidelines for Patients: Chronic Myeloid Leukemia, this fused gene makes a protein that leads to uncontrolled blood cell growth. Treatment specifically targets stopping this BCR::ABL1 protein.

• In AML (Acute Myeloid Leukemia): Various mutations can be actionable, including specific chromosome changes and gene mutations that your pathologist will identify.

What Happens After Testing

Once your genetic testing is complete:

1. Your pathologist reviews the results - A hematopathologist (a specialist in blood cancer cells) analyzes your bone marrow sample and notes the size, shape, and type of cells, plus genetic findings.

2. Your care team discusses findings with you - They'll explain which mutations were found and what treatment options are available for YOUR specific mutations.

3. Treatment is tailored - If actionable mutations are found, your doctor can recommend targeted therapies designed to work against those specific mutations.

Important Questions to Ask Your Care Team

Since this is so important to your treatment plan, here are specific questions to ask:

1. "What genetic and biomarker tests will be done on my leukemia cells?"
2. "When will I have these test results, and who will explain them to me?"
3. "Do my test results show any actionable mutations that affect my treatment options?"
4. "What does each mutation mean for my prognosis and treatment choices?"
5. "Are there any clinical trials available for my specific mutations?"

Key Takeaway

According to the NCCN Guidelines, testing of your leukemia cells gathers specific information to help guide your treatment. You don't need to understand all the technical details—your job is to make sure these tests are done and to ask your care team to explain what the results mean for YOUR specific situation.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.